Metal tools and implements – making
Patent
1984-10-18
1988-01-12
Hollrah, Glennon H.
Metal tools and implements, making
2605011, 26050115, 560 5, 560 38, 560 39, 560252, 564387, 564426, 564341, 564366, 564442, 564446, 564391, 558413, 558422, C07C 9300, C07C 8728, C07C 8764
Patent
active
047190469
ABSTRACT:
The present invention relates to compounds of formula (I)
REFERENCES:
patent: 2734920 (1958-02-01), Hunter et al.
patent: 2865925 (1958-12-01), Bolen
patent: 3052722 (1962-09-01), Ashley et al.
patent: 4034040 (1977-07-01), Cronin et al.
patent: 4511582 (1985-04-01), Bair
patent: 4530800 (1985-07-01), Bair
patent: 4532344 (1985-07-01), Bair
patent: 4551282 (1985-11-01), Bair
Europ. J. Cancer, vol. 3, pp. 75-77, 1967, "Induction Par le 6-Aminochrysene de Remission du Cancer du Sein en Phase Advancee chez la Femme".
Europ. J. Cancer, vol. 6, pp. 81-87, 1970, "The Antitumoral Activity of Some Derivatives of 6-Aminochrysene".
Europ. J. Cancer, vol. 11, pp. 327-334, 1975, "Carcinogenicity of 6-Aminochrysene in Mice".
Letter to the Editor, pp. 477-478, "Preliminary Clinical Screening with 6-Aminochrysene in Lung Cancer".
R. L. Carter and F. J. C. Roe, Chester Beatty Research Institute, "The Carcinogenic Effects of 6-Aminochrysene Administered to Newborn Mice".
Chemotherapia 4: pp. 413-418, 1962, "Action leucopeniante du 6-aminochrysene dans les leucemies myeloides chez I'Homme".
Arzncim-Forsch, Jahrgang 20, No. 4, 1970, pp. 487-494, "Die Solubilisierung therapeutisch verwendeter Arylamine durch n-Propylaminoacetylierung".
Jahrgang 17, Lambelin, Mees, Buu-Hoi/6-Aminochrysene, pp. 1117-1121, "Chronic Toxicity Studies of 6-Aminochrysene in the Rat".
Cancer Chemotherapy Reports Part 1, vol. 57, No. 2, Apr. 1973, "Chemotherapy of a Spontaneous Mammary Carcinoma in Mice".
NG. PH. Buu-Hoi, pp. 721-725, "Some Features of the Chemistry of 6-Aminochrysene".
Xenobiotica, 1976, vol. 6, No. 8, pp. 473-480, "6-Aminochrysene Kinetics in Isolated Perfused Liver".
Europ. J. Cancer, vol. 6, pp. 441-443, 1970, "Experimental Chemotherapy of a Transplantable Rhadomyoscarcoma in the Rat".
Can. J. Chem., vol. 59, 1981, Tadeusz Wieckowski et al, pp. 1622-1629.
Europ. J. Cancer, vol. 12, pp. 227-235, 1976, "The Metabolism of 6-Aminochrysene in the Rat".
NG. PH. Buu-Hoi, pp. 1396-1399, "Some Reactions of 6-Aminochrysene".
Notes, vol. 12, Jul. 1979, pp. 772-773, Bahner, "6-Dimethyl Aminochrysene and Other Analogs of 4-(4-Dimethylamino) Stilbene".
N.P. Buu-Hoi, pp. 71-83, "Some Biological Properties of 6-Aminochrysene and Its Derivatives, A Family of Carcinostatic Compounds Devoid of Cytotoxic Action".
C. R. Acad. Sc. Paris, t. 277 (Oct. 29, 1973), pp. 783-785.
N. P. Buu-Hoi et P. Mabille, pp. 1423-1426, No. 241.
Europ. J. Cancer, vol. 3, p. 79-80, 1967, Letter to the Editor, "Chrysenex in Experimental Advanced Mammary Cancer".
R. Hugonot, pp. 1068-1073.
Academie Nationale de Medecine, pp. 313-317.
Inhibition of the Estrogenic Acticity of Triphenylethylene by 6-Aminochrysene, pp. 119-121.
Derives cancerostatiques de I'amino-6-chrysene et de I'amino-6 diaza-4,10 chrysene, Do-Cao-Thang et al.
Clinical Correlations of In Vitro Drug Sensitivity, p. 245.
Nature, vol. 221, Mar. 15, 1969, pp. 1063-1064.
Carcinogenic Nitrogen Compounds, Part XXV, pp. 2946-2949.
Search Request, USA 1748, STN International Query; -amino chrysene Derivatives.
Brown Donald
Burroughs Wellcome Co.
Covington Raymond
Hollrah Glennon H.
LandOfFree
Crysene derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crysene derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crysene derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-920298